Cara Therapeutics Inc. buy klostergang
Start price
03.04.17
/
50%
€16.64
Target price
23.06.17
€20.75
Performance (%)
24.80%
End price
23.06.17
€20.77
Summary
This prediction ended on 23.06.17 with a price of €20.77. The BUY prediction by klostergang finished with a performance of 24.80%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cara Therapeutics Inc. | -18.483% | -18.483% | -82.768% | -95.027% |
| iShares Core DAX® | -0.530% | 2.858% | 15.472% | 17.034% |
| iShares Nasdaq 100 | -0.580% | 4.871% | 28.534% | 54.277% |
| iShares Nikkei 225® | -1.097% | -1.658% | 7.461% | 3.656% |
| iShares S&P 500 | -0.730% | 2.647% | 24.918% | 45.236% |
Comments by klostergang for this prediction
In the thread Cara Therapeutics Inc. diskutieren
klostergang stimmt der Buy-Einschätzung von marge zu
klostergang stimmt am 03.04.2017 der Buy-Einschätzung von marge mit dem Kursziel 23$ zu.Überschrift: marge stimmt der Buy-Einschätzung von datca zu
Stopped prediction by klostergang for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.51
30.06.17
30.06.17
€18.94
27.06.18
27.06.18
2.18%
27.06.18
27.06.18
